N-[[(3R)-3-(4-chlorophenyl)-2-(2,4-dichlorophenyl)-3,4-dihydropyrazol-5-yl]methyl]-2,1,3-benzoxadiazole-4-sulfonamide

C22H16Cl3N5O3S — CID 59411095

IUPACN-[[(3R)-3-(4-chlorophenyl)-2-(2,4-dichlorophenyl)-3,4-dihydropyrazol-5-yl]methyl]-2,1,3-benzoxadiazole-4-sulfonamide
SMILESO=S(=O)(NCC1=NN(c2ccc(Cl)cc2Cl)[C@@H](c2ccc(Cl)cc2)C1)c1cccc2nonc12
InChIInChI=1S/C22H16Cl3N5O3S/c23-14-6-4-13(5-7-14)20-11-16(27-30(20)19-9-8-15(24)10-17(19)25)12-26-34(31,32)21-3-1-2-18-22(21)29-33-28-18/h1-10,20,26H,11-12H2/t20-/m1/s1
InChIKeyCOKAFSZTIZIUTA-HXUWFJFHSA-N
MW536.83 g/mol
LogP5.47
Rot. Bonds6

About N-[[(3R)-3-(4-chlorophenyl)-2-(2,4-dichlorophenyl)-3,4-dihydropyrazol-5-yl]methyl]-2,1,3-benzoxadiazole-4-sulfonamide

N-[[(3R)-3-(4-chlorophenyl)-2-(2,4-dichlorophenyl)-3,4-dihydropyrazol-5-yl]methyl]-2,1,3-benzoxadiazole-4-sulfonamide (PubChem CID 59411095) has the molecular formula C22H16Cl3N5O3S and a molecular weight of 536.83 g/mol. Its IUPAC name is N-[[(3R)-3-(4-chlorophenyl)-2-(2,4-dichlorophenyl)-3,4-dihydropyrazol-5-yl]methyl]-2,1,3-benzoxadiazole-4-sulfonamide.

Molecular Properties

Compound NameN-[[(3R)-3-(4-chlorophenyl)-2-(2,4-dichlorophenyl)-3,4-dihydropyrazol-5-yl]methyl]-2,1,3-benzoxadiazole-4-sulfonamide
PubChem CID59411095
Molecular FormulaC22H16Cl3N5O3S
Molecular Weight536.83 g/mol
Exact Mass535.00
IUPAC NameN-[[(3R)-3-(4-chlorophenyl)-2-(2,4-dichlorophenyl)-3,4-dihydropyrazol-5-yl]methyl]-2,1,3-benzoxadiazole-4-sulfonamide
SMILESO=S(=O)(NCC1=NN(c2ccc(Cl)cc2Cl)[C@@H](c2ccc(Cl)cc2)C1)c1cccc2nonc12
InChIInChI=1S/C22H16Cl3N5O3S/c23-14-6-4-13(5-7-14)20-11-16(27-30(20)19-9-8-15(24)10-17(19)25)12-26-34(31,32)21-3-1-2-18-22(21)29-33-28-18/h1-10,20,26H,11-12H2/t20-/m1/s1
InChIKeyCOKAFSZTIZIUTA-HXUWFJFHSA-N
XLogP5.47
TPSA100.69 Ų
H-Bond Donors1
H-Bond Acceptors7
Rotatable Bonds6
Heavy Atoms34
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500536.83
LogP ≤ 55.47
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 107

Analyze N-[[(3R)-3-(4-chlorophenyl)-2-(2,4-dichlorophenyl)-3,4-dihydropyrazol-5-yl]methyl]-2,1,3-benzoxadiazole-4-sulfonamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of N-[[(3R)-3-(4-chlorophenyl)-2-(2,4-dichlorophenyl)-3,4-dihydropyrazol-5-yl]methyl]-2,1,3-benzoxadiazole-4-sulfonamide?
The IUPAC name of N-[[(3R)-3-(4-chlorophenyl)-2-(2,4-dichlorophenyl)-3,4-dihydropyrazol-5-yl]methyl]-2,1,3-benzoxadiazole-4-sulfonamide (CID 59411095) is N-[[(3R)-3-(4-chlorophenyl)-2-(2,4-dichlorophenyl)-3,4-dihydropyrazol-5-yl]methyl]-2,1,3-benzoxadiazole-4-sulfonamide.
What is the SMILES notation for N-[[(3R)-3-(4-chlorophenyl)-2-(2,4-dichlorophenyl)-3,4-dihydropyrazol-5-yl]methyl]-2,1,3-benzoxadiazole-4-sulfonamide?
The canonical SMILES for N-[[(3R)-3-(4-chlorophenyl)-2-(2,4-dichlorophenyl)-3,4-dihydropyrazol-5-yl]methyl]-2,1,3-benzoxadiazole-4-sulfonamide is O=S(=O)(NCC1=NN(c2ccc(Cl)cc2Cl)[C@@H](c2ccc(Cl)cc2)C1)c1cccc2nonc12.
What is the InChIKey of N-[[(3R)-3-(4-chlorophenyl)-2-(2,4-dichlorophenyl)-3,4-dihydropyrazol-5-yl]methyl]-2,1,3-benzoxadiazole-4-sulfonamide?
The InChIKey is COKAFSZTIZIUTA-HXUWFJFHSA-N. The full InChI is InChI=1S/C22H16Cl3N5O3S/c23-14-6-4-13(5-7-14)20-11-16(27-30(20)19-9-8-15(24)10-17(19)25)12-26-34(31,32)21-3-1-2-18-22(21)29-33-28-18/h1-10,20,26H,11-12H2/t20-/m1/s1.
What are the key properties of N-[[(3R)-3-(4-chlorophenyl)-2-(2,4-dichlorophenyl)-3,4-dihydropyrazol-5-yl]methyl]-2,1,3-benzoxadiazole-4-sulfonamide?
N-[[(3R)-3-(4-chlorophenyl)-2-(2,4-dichlorophenyl)-3,4-dihydropyrazol-5-yl]methyl]-2,1,3-benzoxadiazole-4-sulfonamide has a molecular weight of 536.83 g/mol, XLogP of 5.47, 6 rotatable bonds, 1 hydrogen bond donors, and 7 hydrogen bond acceptors.
Where does this data come from?
All data for N-[[(3R)-3-(4-chlorophenyl)-2-(2,4-dichlorophenyl)-3,4-dihydropyrazol-5-yl]methyl]-2,1,3-benzoxadiazole-4-sulfonamide is sourced from PubChem (CID 59411095), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).